NanoVibronix Shares Outstanding vs. Current Valuation

NAOV Stock  USD 0.72  0.01  1.37%   
Based on the key profitability measurements obtained from NanoVibronix's financial statements, NanoVibronix may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess NanoVibronix's ability to earn profits and add value for shareholders. At this time, NanoVibronix's Days Sales Outstanding is fairly stable compared to the past year. Days Of Sales Outstanding is likely to climb to 86.39 in 2024, whereas Price To Sales Ratio is likely to drop 0.84 in 2024. At this time, NanoVibronix's Income Tax Expense is fairly stable compared to the past year. Non Operating Income Net Other is likely to climb to about 619.4 K in 2024, whereas Operating Income is likely to drop (3.6 M) in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.610.6732
Moderately Down
Slightly volatile
For NanoVibronix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NanoVibronix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NanoVibronix utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NanoVibronix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NanoVibronix over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoVibronix. If investors know NanoVibronix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoVibronix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.23)
Revenue Per Share
1.502
Quarterly Revenue Growth
1.779
Return On Assets
(0.30)
Return On Equity
(1.41)
The market value of NanoVibronix is measured differently than its book value, which is the value of NanoVibronix that is recorded on the company's balance sheet. Investors also form their own opinion of NanoVibronix's value that differs from its market value or its book value, called intrinsic value, which is NanoVibronix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoVibronix's market value can be influenced by many factors that don't directly affect NanoVibronix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoVibronix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoVibronix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoVibronix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

NanoVibronix Current Valuation vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining NanoVibronix's current stock value. Our valuation model uses many indicators to compare NanoVibronix value to that of its competitors to determine the firm's financial worth.
NanoVibronix is rated below average in shares outstanding category among its peers. It also is rated below average in current valuation category among its peers reporting about  0.41  of Current Valuation per Shares Outstanding. The ratio of Shares Outstanding to Current Valuation for NanoVibronix is roughly  2.46 . Comparative valuation analysis is a catch-all technique that is used if you cannot value NanoVibronix by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

NanoVibronix Current Valuation vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

NanoVibronix

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
3.75 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

NanoVibronix

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
1.52 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

NanoVibronix Current Valuation vs Competition

NanoVibronix is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 33.02 Million. NanoVibronix holds roughly 1.52 Million in current valuation claiming about 5% of equities under Health Care industry.

NanoVibronix Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in NanoVibronix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NanoVibronix will eventually generate negative long term returns. The profitability progress is the general direction of NanoVibronix's change in net profit over the period of time. It can combine multiple indicators of NanoVibronix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-67 K-70.3 K
Operating Income-3.4 M-3.6 M
Income Before Tax-3.7 M-3.9 M
Total Other Income Expense Net-246 K-258.3 K
Net Loss-3.7 M-3.9 M
Income Tax Expense29 K30.4 K
Net Loss-5 M-5.2 M
Net Loss-4.9 M-5.1 M
Interest Income36 K34.2 K
Non Operating Income Net Other590 K619.4 K
Net Interest Income-500 K-525 K
Change To Netincome824.5 K783.3 K
Net Loss(2.12)(2.23)
Income Quality 0.97  0.52 
Net Income Per E B T 1.01  1.11 

NanoVibronix Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on NanoVibronix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NanoVibronix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NanoVibronix's important profitability drivers and their relationship over time.

Use NanoVibronix in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NanoVibronix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoVibronix will appreciate offsetting losses from the drop in the long position's value.

NanoVibronix Pair Trading

NanoVibronix Pair Trading Analysis

The ability to find closely correlated positions to NanoVibronix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NanoVibronix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NanoVibronix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NanoVibronix to buy it.
The correlation of NanoVibronix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NanoVibronix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NanoVibronix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NanoVibronix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your NanoVibronix position

In addition to having NanoVibronix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Trading Thematic Idea Now

Trading
Trading Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Trading theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Trading Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for NanoVibronix Stock Analysis

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.